36.73 0.00 (0.00%)
After hours: 7:59PM EST
|Bid||36.74 x 3100|
|Ask||36.72 x 900|
|Day's Range||36.62 - 37.00|
|52 Week Range||26.45 - 43.08|
|Beta (5Y Monthly)||0.64|
|PE Ratio (TTM)||23.88|
|Earnings Date||Feb. 02, 2021|
|Forward Dividend & Yield||1.56 (4.25%)|
|Ex-Dividend Date||Jan. 28, 2021|
|1y Target Est||41.79|
Emergency Medicine Physician Dr. Steven McDonald joins Yahoo Finance's Kristin Myers to break down the latest coronavirus developments, as U.S. hospitalizations begin to decline.
U.S. hits 400,000 deaths as virus spread continues to overwhelm parts of the country. Meanwhile, vaccine chaos hampers efforts.
China's Sinopharm Group and Pfizer Inc have requested approval for use of their COVID-19 vaccines in Peru as the Andean country grapples with a second wave of the coronavirus, a health official said on Tuesday. Carmen Ponce, general director of state drug regulator Digemid, said both drugmakers requested the registration last week after presenting "preliminary information" from their Phase III COVID-19 vaccine trials. Ponce added that authorization requests from other vaccine makers, such as AstraZeneca Plc and Russia's Gamaleya, are expected in the next few days.